Design and synthesis of novel pyrrolo[2,1-c][1,4]benzodiazepine-lexitropsin conjugates

被引:50
作者
Damayanthi, Y [1 ]
Reddy, BSP [1 ]
Lown, JW [1 ]
机构
[1] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada
关键词
D O I
10.1021/jo9812072
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:290 / 292
页数:3
相关论文
共 34 条
[21]  
Lown J. William, 1994, Journal of Molecular Recognition, V7, P79, DOI 10.1002/jmr.300070205
[22]   STUDIES RELATED TO ANTI-TUMOR ANTIBIOTICS .16. MOLECULAR MECHANISM OF BINDING OF PYRROLO(1,4)BENZODIAZEPINE ANTI-TUMOR AGENTS TO DEOXYRIBONUCLEIC-ACID - ANTHRAMYCIN AND TOMAYMYCIN [J].
LOWN, JW ;
JOSHUA, AV .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) :2017-2026
[23]   SYNTHESIS OF PYRROLO[2,1-C][1,4]BENZODIAZEPINES VIA AN INTRAMOLECULAR AZA-WITTIG REACTION - SYNTHESIS OF THE ANTIBIOTIC DC-81 [J].
MOLINA, P ;
DIAZ, I ;
TARRAGA, A .
TETRAHEDRON, 1995, 51 (19) :5617-5630
[24]   DNA-SEQUENCE SELECTIVITIES IN THE COVALENT BONDING OF ANTIBIOTIC SAFRAMYCIN-MX1, SAFAMYCIN-MX3, SAFAMYCIN-A, AND SAFAMYCIN-S DEDUCED FROM MPE.FE(II) FOOTPRINTING AND EXONUCLEASE-III STOP ASSAYS [J].
RAO, KE ;
LOWN, JW .
BIOCHEMISTRY, 1992, 31 (48) :12076-12082
[25]   MODE OF ACTION OF SAFRAMYCIN ANTITUMOR ANTIBIOTICS - SEQUENCE SELECTIVITIES IN THE COVALENT BINDING OF SAFRAMYCIN-A AND SAFRAMYCIN-S TO DEOXYRIBONUCLEIC-ACID [J].
RAO, KE ;
LOWN, JW .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (03) :262-267
[26]  
RAO KE, 1990, ANTI-CANCER DRUG DES, V5, P3
[27]  
REMERS WA, 1988, CHEM ANTITUMOR ANTIB, V2, P28
[28]  
SCHIMIZU K, 1982, J ANTIBIOT, V35, P992
[29]  
Sondhi SM, 1997, CURR MED CHEM, V4, P313
[30]  
Thurston D.E., 1993, MOL ASPECTS ANTICANC, P54